fantastic news...and promising for the next sample resultsneeded a good annoc to see this reach its next level..one to follow and watch close..should see more upward trends over the next few weeks imo.....
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%